Lifesci Acquisition Corp.
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
$0.81avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Lifesci Acquisition Corp. in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Hollencrest Capital Management ($8K).
- Company
- Lifesci Acquisition Corp.
- Filed as
- VINCERX PHARMA INC COM NEW (Q2 2024)
- CUSIP
- 53228P109
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $38K |
All 13F filers, Q1 2024 → Q2 2024: 7,500 shares sold, net −7,500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Hollencrest Capital Management | 0.00% | No change | 10,000 | $8K |
"% of holder's portfolio" is LIFESCI ACQUISITION CORP's weight in each manager's 13F, not the share of Lifesci Acquisition Corp. the manager owns.